CMS Revisits GLP-1 Drug Coverage for Obesity in Medicare, Medicaid Pilot
CMS is considering a pilot program to cover GLP-1 drugs for obesity under Medicare and Medicaid, reversing earlier policy. This evolving coverage changes obesity drug access for patients and payers.